Biointerface-Engineered Gold and Silver Nanoparticles for Skin Cancer Therapy: Linking Nano-Biointerface Design to Therapeutic Function and Clinical Translation.
Sep 2026· Journal of drug targeting (Print)· pp.
1-26
· 0 citations· 49 references
Medicine
TL;DR
The reviewed evidence indicates that AuNPs are particularly suited to photothermal and photodynamic therapies because their plasmonic properties enable localized light-mediated effects, whereas AgNPs exhibit prominent cytotoxic activity associated with reactive oxygen species generation and modulation of the tumour microenvironment.
Abstract
Skin cancer therapy continues to face challenges in achieving selective tumour targeting while limiting damage to healthy tissue. Gold nanoparticles (AuNPs) and silver nanoparticles (AgNPs) have emerged as versatile platforms for skin cancer treatment, but their therapeutic behaviour is strongly influenced by the nano-biointerface. This review critically examines how particle size, morphology, surface chemistry, ligand functionalization, and biomimetic coatings influence skin penetration, cellular uptake, tumour localization, and therapeutic activity. The reviewed evidence indicates that AuNPs are particularly suited to photothermal and photodynamic therapies because their plasmonic properties enable localized light-mediated effects, whereas AgNPs exhibit prominent cytotoxic activity associated with reactive oxygen species generation and modulation of the tumour microenvironment. Biointerface engineering can further enable active targeting, improve colloidal stability, alter biodistribution, and integrate multiple therapeutic functions. However, reported improvements in therapeutic efficacy are accompanied by unresolved concerns regarding nanoparticle stability, reproducibility, long-term toxicity, biodistribution, and standardization. Overall, the evidence indicates that nanoparticle performance cannot be considered independently of the nano-biointerface. Rational control of interfacial properties is therefore central to improving targeting precision and therapeutic performance, while standardized characterization, mechanistic understanding, and systematic safety evaluation remain essential for clinical translation.
Gold nanoparticles (AuNPs) are versatile cancer-therapy platforms with tunable plasmonic properties, high atomic number, accessible surface chemistry, and potential for integration into theranostic systems. By controlling size, morphology, surface composition, and cargo-loading strategies, AuNPs can support phototherma...
Xiang-Hua Ma, Wen Xu, C. Chittasupho et al.· Pharmaceutics· 0 citations
As of late, gold nanoparticles (AuNPs) are gaining recognition as highly versatile nano-materials with remarkable potential in biomedical applications, owing to their unique physicochemical properties. Aside from their tunable size and shape and well-defined surface chemistry, AuNPs provide strong biocompatibility and...
Maria Lyudmilova, Lyubomir Stoychev, J. Genova· Applied Sciences· 0 citations
Cutaneous melanoma is an aggressive malignancy for which conventional treatments are often limited by acquired resistance, systemic toxicity, and insufficient dermal penetration. To overcome these therapeutic limitations, green nanomedicine has emerged as a promising alternative, employing biological systems such as pl...
Metallic gold and silver nanoparticles have been extensively studied as nanoscale technologies for targeted gene and drug delivery agents. This narrative review incorporates the latest advances in the therapeutic and diagnostic potential of gold nanoparticles (AuNPs) and silver nanoparticles (AgNPs) while also critical...
Pratiksha Jadaun, Devangini Sharma, J. Banerjee et al.· Discover Nano· 0 citations
OBJECTIVES
Cancer remains a major global health challenge despite significant advances in diagnosis and treatment. Conventional therapies, including chemotherapy, radiotherapy, and surgery, are frequently constrained by non-specific drug distribution, systemic toxicity, multidrug resistance (MDR), and limitations in ea...
Shivangi Dubey, SnehaM Prakash, R. Deshwal et al.· The Journal of pharmacy and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.